Arifa Naeem
About Arifa Naeem
Arifa Naeem is a Preclinical Senior Research Scientist at MeiraGTx, specializing in the development of toxicity and potency assays for viral vectors. She focuses on innovative techniques in preclinical research, particularly in the context of inherited retinal diseases and neurodegenerative disorders.
Work at MeiraGTx
Arifa Naeem has been serving as a Preclinical Senior Research Scientist at MeiraGTx since 2019. In this role, she develops toxicity and potency assays using immortalised cell lines for various viral vectors. Her work is integral to maintaining the company's research platforms at the forefront of preclinical development. Naeem focuses on establishing new techniques and protocols that enhance the efficiency and effectiveness of research initiatives.
Education and Expertise
Arifa Naeem earned her Master of Science in Microbiology from Birkbeck, University of London, where she studied from 1988 to 1990. Her educational background provides a solid foundation for her extensive experience across multiple disciplines, including Microbiology, Gastroenterology, Neurobiology, and Ophthalmology. This diverse expertise supports her current research efforts in the field of gene and cell therapies.
Research Initiatives
In her current role, Arifa Naeem is involved in generating organoid platforms using stem cells. These platforms are utilized to test and validate viral vectors specifically for inherited retinal diseases and neurodegenerative disorders. Her research aims to advance the understanding and treatment of these conditions through innovative methodologies.
Professional Experience
With over five years of experience at MeiraGTx, Arifa Naeem has developed a robust skill set in preclinical research. She utilizes pharmacological agents and growth factors in her studies, contributing to the development of therapies aimed at addressing complex medical challenges. Her multidisciplinary approach enhances the research capabilities of her team.